Physician profile
Robert P Taylor
NPI 1558433458
$99,400.85
in general payments reported to CMS, 2019-2025
9 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $17K · 2021: $20K · 2022: $32K · 2023: $5,355 · 2024: $4,694 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,200 · Travel and Lodging: $659 · Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,200.00 |
| Travel and Lodging | $658.91 |
| Food and Beverage | $464.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $94,636.14 | 2019-2025 | |
| Pylant Medical | $4,053.09 | 2019-2025 | |
| Stryker Corporation | $446.30 | 2019-2024 | Easyfuse, Infinity, Augment Injectable |
| Horizon Therapeutics Plc | $137.34 | 2019-2020 | |
| Depuy Synthes Sales INC. | $33.72 | 2022 | |
| Smith+Nephew, INC. | $31.11 | 2024 | Coblation |
| Averitas Pharma INC. | $26.95 | 2024 | Qutenza |
| Wright Medical Technology, INC. | $21.04 | 2020 | |
| Terumo Bct, INC. | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.